Biggest News Aggregation in the World
📰 Analyst Views News

Analyst Views News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Analyst Views. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Hereditary Angioedema Pipeline, Clinical and Non-Clinical Products and FDA Approvals 2023 (Updated)

DelveInsights, Hereditary Angioedema Pipeline Insight 2023 report provides comprehensive insights about 20+ companies and 30+ pipeline drugs in the Hereditary Angioedema pipeline landscape. It...
United States Yash Bhardwaj Las Vegas Hereditary Angioedema Biocryst Pharmaceuticals Kalvista Pharmaceuticals Mid Stage Products Phase Company Name Inactive Products Hereditary

d-mart stock update: D-Mart Q1 Preview: PAT growth likely to trail sales as margin under pressure

Ahead of its earnings, shares of the company end 0.5% higher on the National Stock Exchange at Rs 3,838.75. In the June quarter, the stock has gained more than 14% and scaled an over 6-month high of Rs 4,150 last month.
Prabhudas Lilladher National Stock Exchange At Rs Avenue Supermarts Radhakishan Damani Owned National Stock Exchange D Mart Stock Update

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science